Agenus Inc
NASDAQ:AGEN
Agenus Inc
NASDAQ:AGEN
Price:
10.86 USD
3.43%
Market Closed
Updated:
May 18, 2024
Agenus Inc
Research & Development
|
Agenus Inc
Research & Development Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Agenus Inc
NASDAQ:AGEN
|
Research & Development
-$221.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-31%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$4.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
See Also
What is Agenus Inc's Research & Development?
Research & Development
-221.3m
USD
-221.3m
USD
Based on the financial report for Mar 31, 2024, Agenus Inc's Research & Development amounts to -221.3m USD.
What is Agenus Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-31%
-31%
Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Agenus Inc have been -16% over the past three years , -10% over the past five years , and -31% over the past ten years .
You don't have any saved screeners yet
